Health
PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro – News-Medical.Net
A team of researchers from the Northern Arizona University evaluated a new PARP inhibitor, stenoparib, which has recently advanced to Stage II of clinical trials…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus, originated from Wuhan, China, in late December 2019 and rapidly spread across the globe, progressing into a devastating pandemic. To date, the COVID-19 pandemic has caused 54.3 million infections and over 1.31 million deaths worldwide.
In the absence of a vaccine, COVID-19 can continue to cause significant morbidity and mortality
Coronavirus disease (COVID-19) affects the upper and lower respiratory systems and…
-
Noosa News20 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General20 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News12 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General9 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania